Cancer Prevention Science Blog

A research blog from the NCI Division of Cancer Prevention

Due to restructuring and reductions in force at the US Department of Health and Human Services (HHS), the DCP Cancer Prevention Science blog will no longer be published. Thank you very much for your support over the years.

Important Symptom Management Findings Presented at 2023 ASCO Meeting

June 13, 2023 | By DCP Staff

A medical provider checking in with a patient.

Results from two NCI-supported studies relating to symptom management were among the significant findings presented at the June 2023 ASCO meeting. The findings, which both incorporated data from patient-reported outcomes (PROs), have the potential to help reduce toxic side effects and improve quality of life for people with cancer.

Research Highlights: Investigating Associations of Obesity with Colorectal and GI Cancers

June 5, 2023 | By DCP Staff

A 3D rendering of the human gastrointestinal tract.

An estimated 153,020 men and women in the U.S. will be diagnosed with colorectal cancer in 2023, and 52,550 are expected to die of this disease. In two recent studies, researchers addressed the impact of overweight, obesity, and body mass index (BMI) on colorectal and non-colorectal gastrointestinal (GI) cancers at different stages of adult life, as well as the association of BMI and different molecular subtypes in colorectal cancers.

Eliminating Underlying Liver Disease Remains Key Strategy for Liver Cancer Prevention

May 4, 2023 | By Susan Jenks

An illustration depicting a human liver.

Despite intense research, liver cancer prevention remains a challenge. Current efforts are directed at underlying conditions that can significantly raise an individual’s risk, including hepatitis C infection, for which researchers are working to find a vaccine.

NCI Supports New Research into Prevention of Early-Onset Colorectal Cancer

March 22, 2023 | By Susan Jenks

Symptoms of Colorectal Cancer: Changes in Bowel Habits, Blood or Changes in Stool, Pain and Bloating, Weight Loss

Early-onset colorectal cancer is considered relatively rare, but both incidence and mortality rates are increasing in people under age 50. NCI recently issued a special research request for grant applications–in areas such as risk factors, biomarkers, screening methods, and preventive interventions.

Trials Test Vaccines for Prevention or Delay of Cancers Associated with Lynch Syndrome

February 8, 2023 | By Susan Jenks

Researchers have recruited the first vaccine candidates to one of two new prevention trials that seek to immunize high-risk individuals against cancers associated with Lynch syndrome, the most common cause of hereditary colorectal cancer. Individuals who inherit the condition have an estimated lifetime risk as high as 80% for developing one of these malignancies, as well as an above-average risk for cancers arising in other organs, often at an early age, and regardless of race or gender.